Balaji Amines Ltd Q1 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/4tqxlt8gectjq8d069ydrwyf.pdf

Key Takeaways


Demand & Pricing Environment

Ram Reddy: "Definitely the current situation has bottomed up. I don't think the prices will go further down. We see from here onwards, there should be some improvement and maybe in coming one quarters or two quarters, prices should be stable at normal level from these bottoms."

Product-Level Challenges

Ram Reddy: "Actually dumping is happening in the country. Very unfortunate we are not getting government support for the antidumping."

Expansion Projects & Timelines

Ram Reddy: "We have not taken the current situation as a permanent thing. We have not stopped our expansions. All the expansions, maybe one or two months here and there, are progressing as decided earlier."

DME: The Game-Changer Bet

Ram Reddy: "I feel, it is my personal view, the Dimethyl Ether should be big game changer for the company."

Financial Targets & Capital Allocation


Guidance & Commitments

CommitmentSpecificsTimeline
n-Butylamine plant commissioning15,000 tons capacityDecember 2023
Methylamine plant commissioning40,000 tons capacityJune 2024
DME plant commissioning100,000 tons capacityEnd of FY2025
DMAHCL plant commissioning7,500 tons capacityEnd of H2 FY2024
Unit 4 phased production startPhase 2 and 3 projectsH2 FY24 onwards
Price normalization to normal levelsFrom current bottomed-out levelsLast quarter of current financial year
DMF capacity utilizationMinimum 60%-70%No specific timeline
DMC and PG capacity utilizationMinimum 50%-60%Before end of this year
n-Butylamine first-year sales8,000-9,000 tonsFirst year of operation
n-Butylamine full capacity100% utilizationWithin two years of commissioning
Revenue targetINR 3,000 crores (plus or minus)FY24-25
Revenue targetINR 4,000 croresFY26-27
Consolidated EBITDA margin20% to 22%Ongoing
Export mix targetMinimum 20%-22%No specific timeline given
DME government blending order25% DME in LPG mandateExpected in 2-3 weeks from call date

Key Metrics

MetricQ1 FY24
Revenue from operations₹469.32 cr, vs ₹674.86 cr in Q1 FY23
Total volume26,820 metric tons, vs 27,358 metric tons in Q1 FY23
EBITDA₹103.69 cr, vs ₹219.48 cr in Q1 FY23
EBITDA margin22.09%, vs 32.52% in Q1 FY23
PAT₹67.68 cr, vs ₹148.04 cr in Q1 FY23
Diluted EPS₹16.28 per equity share, vs ₹37.95 in Q1 FY23
Amines volume6,757 metric tons
Amines derivatives volume8,288 metric tons
Specialty chemicals volume11,775 metric tons
Standalone debtZero debt
Overall average capacity utilization60% to 70% of total installed capacity
DMF capacity utilization40% to 45%
DMC and Propylene Glycol capacity utilization20% to 25%
Ethylamine capacity utilizationMore than 90%
Export share (standalone)15%, with a target of 20% to 22% going forward
Pharma end-user exposureMore than 55% to 60%
Agrochemical end-user exposureAround 25% to 26%
Revenue target for FY24-25Plus or minus ₹3,000 cr, on stable normal pricing levels
Revenue target for FY26-27₹4,000 cr, on stable normal pricing levels